{
  "id": "601ebc241cb411341a00005c",
  "type": "summary",
  "question": "Explain the use of Radio Frequency Ablation as a treatment",
  "ideal_answer": "Radio-frequency ablation (RFA) is a promising minimal-invasive treatment option for treatment of, cancer, pain, tissue hyperplasia and cardiac arrhythmias cancer, triggering tissue necrosis and results in reduced tumor volumes.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/12376615",
    "http://www.ncbi.nlm.nih.gov/pubmed/15947578",
    "http://www.ncbi.nlm.nih.gov/pubmed/26361338",
    "http://www.ncbi.nlm.nih.gov/pubmed/25992184",
    "http://www.ncbi.nlm.nih.gov/pubmed/31065438",
    "http://www.ncbi.nlm.nih.gov/pubmed/18670269",
    "http://www.ncbi.nlm.nih.gov/pubmed/7900601",
    "http://www.ncbi.nlm.nih.gov/pubmed/11110923",
    "http://www.ncbi.nlm.nih.gov/pubmed/30396206",
    "http://www.ncbi.nlm.nih.gov/pubmed/29372343",
    "http://www.ncbi.nlm.nih.gov/pubmed/1417404",
    "http://www.ncbi.nlm.nih.gov/pubmed/17981554",
    "http://www.ncbi.nlm.nih.gov/pubmed/21496837",
    "http://www.ncbi.nlm.nih.gov/pubmed/11779979",
    "http://www.ncbi.nlm.nih.gov/pubmed/25106899",
    "http://www.ncbi.nlm.nih.gov/pubmed/15749505",
    "http://www.ncbi.nlm.nih.gov/pubmed/11598245",
    "http://www.ncbi.nlm.nih.gov/pubmed/12751862",
    "http://www.ncbi.nlm.nih.gov/pubmed/10751849",
    "http://www.ncbi.nlm.nih.gov/pubmed/15663674",
    "http://www.ncbi.nlm.nih.gov/pubmed/18423723",
    "http://www.ncbi.nlm.nih.gov/pubmed/31644405",
    "http://www.ncbi.nlm.nih.gov/pubmed/19357382",
    "http://www.ncbi.nlm.nih.gov/pubmed/32902841",
    "http://www.ncbi.nlm.nih.gov/pubmed/12418770",
    "http://www.ncbi.nlm.nih.gov/pubmed/25571196",
    "http://www.ncbi.nlm.nih.gov/pubmed/9480582",
    "http://www.ncbi.nlm.nih.gov/pubmed/22335865",
    "http://www.ncbi.nlm.nih.gov/pubmed/22357170",
    "http://www.ncbi.nlm.nih.gov/pubmed/7944863",
    "http://www.ncbi.nlm.nih.gov/pubmed/12441926",
    "http://www.ncbi.nlm.nih.gov/pubmed/12441927",
    "http://www.ncbi.nlm.nih.gov/pubmed/20017327",
    "http://www.ncbi.nlm.nih.gov/pubmed/26905020",
    "http://www.ncbi.nlm.nih.gov/pubmed/29696193"
  ],
  "snippets": [
    {
      "text": "Radio-frequency ablation (RFA) is a promising minimal-invasive treatment option for early liver cancer, however monitoring or predicting the size of the resulting tissue necrosis during the RFA-procedure is a challenging task, potentially resulting in a significant rate of under- or over treatments",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29696193",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Endoscopy treatment includes a wide range of resection and ablative techniques, such as radio-frequency ablation (RFA), often concomitantly used in everyday endoscopy practice (multimodal therapy). RFA promotes mucosal necrosis of treated oesophagal region via high-frequency energy",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31644405",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Our aim was to evaluate the safety and efficacy of percutaneous radio frequency ablation (RFA) in reducing clinical symptoms, fibroid volume and improving laboratory parameters.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32902841",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " Cooled radio frequency ablation (C-RFA) is a treatment with the potential to provide pain relief for patients who no longer benefit from noninvasive modalities and who desire an alternative to surgery.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30396206",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Peripheral nerve pain is common among patients with typical management including the use of pain medications, neuropathic agents, steroid injections, and nerve blocks. Additionally, the use of pulsed radiofrequency (PRF) and radiofrequency ablation (RFA) can be used in the management of chronic peripheral nerve pain.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29372343",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Previous studies investigating the effectiveness of RFA and PRF, typically case reports, have demonstrated that peripheral nerve RFA and PRF have the potential to provide relief of chronic pain for long duration",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29372343",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Our study aimed at testing efficacy of RFA/PRF for treating peripheral neuralgia",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29372343",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "RFA and PRF can be used to treat chronic peripheral pain after conservative methods fail to do so. Large clinical trials are needed to confirm our finding.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29372343",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Radiofrequency ablation (RFA) is an important standard therapy for cardiac arrhythmias, but direct monitoring of tissue treatment is currently lacking. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31065438",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE: To evaluate the feasibility of sonographically guided radio frequency thermal ablation as a minimally invasive method for treatment of unresectable recurrent or metastatic tumors in the retroperitoneum and the pelvis, which often pose difficult surgical problems.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12751862",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "SIONS: Minimally invasive sonographically guided radio frequency thermal ablation is technically feasible for local treatment of unresectable recurrent retroperitoneal and pelvic tumors from different origins. Care ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12751862",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "PURPOSE: Radio frequency ablation is an emerging nephron sparing treatment option in select patients with small renal tumors.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18423723",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "TERIALS AND METHODS: We identified 159 tumors treated with radio frequency ablation as primary treatment. D",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22335865",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "SIONS: Radio frequency ablation treatment success of the small renal mass is strongly correlated with tumor size. Radio",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22335865",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "PURPOSE: To evaluate the feasibility of a technique of MR-guided stereotactic radio frequency ablation, which was developed as a minimally invasive treatment for brain tumors, and to determine MR characteristics and sequential evolution of radio frequency lesions created to ablate brain tumors.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/7900601",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Tumor ablation by using radio-frequency energy has begun to receive increased attention as an effective minimally invasive approach for the treatment of patients with a variety of primary and secondary malignant neoplasms",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11110923",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "radio-frequency ablation has been shown to be an effective method to treat BE, although there is disagreement as to whether radio-frequency ablation should be used to treat all patients with BE or whether treatment should be reserved for those at high risk for progressing to esophageal adenocarcinoma while continuing to endoscopically survey those with low risk. Recent res",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25992184",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The series of five patients with symptomatic isolated right ventricular outflow tract ectopy and no structural heart disease which were successfully treated with radiofrequency ablation of the ectopic focus are reported in order to discuss radio-frequency ablation as an alternative treatment in patients with right ventricular outflow tract ectopy without ventricular tachycardia",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9480582",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "adio-Frequency Ablation (RFA) is a minimally invasive technique which is used as standard local therapy of primary and metastatic liver tumors. T",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17981554",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Minimally-invasive treatments of cardiac arrhythmias such as radio-frequency ablation are gradually gaining importance in clinical practice but still lack a noninvasive imaging modality which provides insight into the source or focus of an arrhythmia",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26361338",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND AND PURPOSE: Combining percutaneous plasma-mediated radio-frequency (pmRF) ablation with vertebral body augmentation offers an alternative treatment to surgical intervention options for advanced metastatic spinal lesions and is particularly useful for cases with cortical destruction and",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19357382",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Recently, Radio Frequency Ablation (RFA) is becoming a popular therapy for various cancers such as liver, breast, or lung cancer. RFA",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25571196",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE: Although radio-frequency ablation (RFA) has been recently applied as a minimally invasive treatment option for renal cell carcinoma (RCC), indication of this modality remains a critical issue due to the lack of complete tumor destruction as well as the uncertainty of its long-term efficacy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15663674",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Recently, radio-frequency ablation has been shown to be an effective method to treat BE, although there is disagreement as to whether radio-frequency ablation should be used to treat all patients with BE or whether treatment should be reserved for those at high risk for progressing to esophageal adenocarcinoma while continuing to endoscopically survey those with low risk.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25992184",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The series of five patients with symptomatic isolated right ventricular outflow tract ectopy and no structural heart disease which were successfully treated with radiofrequency ablation of the ectopic focus are reported in order to discuss radio-frequency ablation as an alternative treatment in patients with right ventricular outflow tract ectopy without ventricular tachycardia.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/9480582",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "SETTING: Teaching hospital.PATIENT(S): Women suffering from dysfunctional uterine bleeding.INTERVENTION(S): Bipolar radio frequency ablation and thermal balloon ablation.MAIN OUTCOME MEASURE(S): Patients were asked to complete HRQoL questionnaires at baseline, and at 2 days, 2 weeks, 3 months, 6 months, and 12 months after surgery.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15749505",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "METHODS: We reviewed our radio frequency ablation database of patients with renal masses undergoing laparoscopic or computerized tomography guided percutaneous radio frequency ablation with simultaneous peripheral fiberoptic thermometry from November 2001 to January 2011 at a single tertiary care center.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22357170",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Subanalysis of the 212 (67%) renal cell carcinoma tumors showed a 3-year Kaplan-Meier estimation of oncologic recurrence-free probability (post-ablation biopsy proven viable tumor) of 94% for computerized tomography guided radio frequency ablation and 100% for laparoscopic radio frequency ablation (p=0.16).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22357170",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "They were organized into five categories: understanding the mechanisms and principles of radio-frequency ablation, modulation of tissue physiologic characteristics to increase tumor destruction, strategies of overlapping ablations, strategies to improve ablation according to tumor location, and imaging strategies after ablation to ensure adequate therapy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11598245",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CONCLUSIONS: Radio frequency ablation treatment success of the small renal mass is strongly correlated with tumor size.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22335865",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Following surgical exposure of the kidney a single 12-minute radio frequency ablation of the tumor was performed using the Radionics Cool-tip RF Radio Frequency Ablation System (Radionics, Burlington, Massachusetts).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12441926",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Compared with the laparoscopic partial nephrectomy group, patients in the laparoscopic radio frequency ablation assisted tumor enucleation group had a smaller decrease in glomerular filtration rate of the affected kidney at 3 months (10.2% vs 20.5%, p=0.001) and 12 months (7.6% vs 16.2%, p=0.002).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26905020",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "This review aims to explain distinct effects of PPIs and RFA modalities, illuminate certain aspects of molecular mechanisms involved, as well as the effects of their concomitant use regarding the treatment of BE and prevention of its transfer to EAC.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31644405",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE: To explore the clinical value of CT guided radio frequency ablation in the treatment of pelvis tumor.M",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20017327",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "1 males and 8 females ranging from 25 to 49 years old (average 37) were enrolled in this study, all the 19 patients were suffering from pelvis tumor including giant cell tumor of bone (2/19), Ewing's sarcoma (2/19), malignant fibrous histiocytoma (3/19) and metastatic diseases (12/19). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20017327",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "yoablation and radio frequency ablation are effective treatment modalities for small renal masses in the infirm patient. G",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18670269",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Probe ablative treatment for small renal masses: cryoablation vs. radio frequency ablation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18670269",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Radio frequency ablation is an effective treatment for focal renal cell carcinoma (RCC).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12418770",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "atients. We present our experience with radio frequency interstitial tissue ablation, a heating device approved by the Food and Drug Administration for treating soft tissue tumors.MATERIALS AND METHODS: Patients underwent radio frequency interstitial tissue ablation of small renal tumor",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10751849",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "hey required more frequent intervention. Radio frequency ablation became the most widely used second or third line procedure and allowed renal salvage in 8 patients.CONCLUSIONS: Nephron sparing surgery and more recently radio frequency ablation enable earlier treatment of smaller tumors and are associated with a significant improved renal",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21496837",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "examined with hematoxylin and eosin or NADH staining. We believe that radio frequency interstitial tumor ablation of renal cell carcinoma without subsequent tissue resection should continue to be an investigational treatment modality for those who w",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12441927",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "PURPOSE: To evaluate the feasibility of a technique of MR-guided stereotactic radio frequency ablation, which was developed as a minimally invasive treatment for brain tumors, and to determine MR characteristics and sequential evolution of radio frequency lesions created to ablate brain tumors.METHODS: Fourteen lesions in 12 patients with primary and metastatic brain tumors were treated with this technique and followed fo",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/7900601",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE: To evaluate the feasibility of sonographically guided radio frequency thermal ablation as a minimally invasive method for treatment of unresectable recurrent or metastatic tumors in the retroperitoneum and the pelvis, which often pose difficult surgical problems.METHODS: Radio frequency thermal ablation was performed on 7 patients with unresectable recurrent retroperitoneal or pelvic tumors from colorectal (n = 4), renal (n = 2), and prost",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12751862",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "[Ablation by radiofrequency in the treatment of atrial arrhythmia].",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/7944863",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "PURPOSE: We defined the role of radio frequency ablation in the treatment of renal cell carcinoma.MATERIALS AND METHODS: A total of 16 patients with biopsy proven renal cell carcinoma were treated with radio frequency ablation in an outpatient setting and followed for a minimum of 4 years.RESULTS: Of the 16 patients 5 died before",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15947578",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ence, pain relief was noted to occur very rapidly in 100% of cases. In agreement with the literature data, our results show that CT-guided percutaneous radio-frequency ablation can actually replace operative excision in the treatment of osteoid osteoma as it",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11779979",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "hanced T1-weighted images. The sequential MR imaging showed the radio frequency lesions decreased in volume in all cases, suggesting focal control.CONCLUSION: Stereotactic MR-guided radio frequency brain tumor ablation is a feasible and promising technique that can be an attrac",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/7900601",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "These results suggest radio-frequency energy is a seductive alternative to direct current ablation for percutaneous modification of atrioventricular conduction in patients with refractory atrial arrhythmias.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/1417404",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " 89.7% (95% CI 78.5-97.9), respectively. The percent decrease in the glomerular filtration rate was significantly lower in the radio frequency ablation group at early and last followup.CONCLUSIONS: In appropriately selected patients with stage cT1b renal cell carcinoma radio frequency ablation is an effective treatment option that provides 5-year overall, cancer specific and disease-free survival comparable to that of partial nephrectomy as well as better",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25106899",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE: To explore the clinical value of CT guided radio frequency ablation in the treatment of pelvis tumor.METHODS: 11 males and 8 females ranging from 25 to 49 years old (average 37) were enrolled in this study, all the 19 patients were suffering from pelvis tumor including giant cell tumor of bone (2/19), Ewing's sarcoma (2/19), malignant fibrous histiocytoma (3/19) and metastat",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20017327",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In patients with metastatic disease, RF ablation may be suitable for treatment of a small tumor burden or for palliation of larger tumors that cause symptoms such as cough, hemoptysis, or pain.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12376615",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In patients with non-small cell lung malignancy who are not candidates for surgery owing to poor cardiorespiratory reserve, RF ablation alone or followed by conventional radiation therapy with or without chemotherapy may prove to be a treatment option.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12376615",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": []
}